Proscia Secures $46M for Mainstream AI Pathology Platform
04:52 Share

In this episode, we delve into how Proscia's recent $46 million Series C funding round is setting the stage for AI-driven pathology to become a mainstream tool in healthcare. We'll explore the implications of this significant investment for the future of pathology and patient care.

Get on the AI Box Waitlist: ⁠⁠⁠⁠⁠⁠https://AIBox.ai/⁠⁠⁠⁠⁠⁠) Facebook Community: ⁠⁠⁠⁠⁠https://www.facebook.com/groups/739308654562189⁠⁠⁠⁠) Follow me on X: ⁠⁠⁠⁠⁠⁠https://twitter.com/jaeden_ai)